Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 4, 28 April 2023
Open
Access | Article
The Role of A High-Carbohydrates Diet on Alzheimer’s Disease
* Author to whom correspondence should be addressed.
Abstract
Brain diseases, like majority illnesses, are influenced in some way by nutrition. Alzheimer’s disease, which is characterized by brain cell deaths and memory loss, is significantly influenced by sugar intake. The frequency, quantity, and type of carbohydrates can influence AD development and outcomes. Whether highly processed or not, carbohydrate-rich foods influence AD. This paper discusses how a high-carbohydrate diet increases the chances of AD development and aggravation. General introduction to carbohydrate diets and the etiology of AD are explained. Subsequently, details on nonmodified and modified AD risk factors are addressed. The present paper moreover examines the imperative relationship between AD and high-carbohydrates diets. Particularly, the paper elucidates how: carbohydrate-rich diets impair cognitive function; how the diet aggravates AD ramifications. Furthermore, the paper evaluates how high-carbohydrates diets: alter AD biomarkers; interact with age to influence AD; and how carbohydrate-rich diets prevent brain cell growth and repair. The report addresses the prevailing therapeutic methods that can be employed to prevent and manage Alzheimer’s disease. Such interventions include the use of caffeine to significantly less cognitive deterioration in AD patients is addressed. Other interventions addressed regard how ketogenic diets can effectively aid with AD prevention; minimal sugar consumption; and how physical activities can aid AD prevention and management. Besides, AD-derived diseases are also addressed. The paper finds that high-carbohydrate diets should be avoided, and healthier lifestyle practices are integral for AD prevention and management.
Keywords
High-Carbohydrates Diet, Ketogenic Diet, Inflammation, Amyloidosis, Alzheimer’s Disease
References
1. Z. Breijyeh,R. Karaman, "Comprehensive Review on Alzheimer's Disease: Causes and Treatment," Molecules, 25(24) (2020).
2. J. H. Cummings,A. M. Stephen, "Carbohydrate terminology and classification," European Journal of Clinical Nutrition, 61(S1), S5-S18 (2007).
3. T. Qiu, "The potential mechanism underlying hippocampus-dependent memory decline caused by high-fat and high-sugar diet and the interventions to combat diet-induced cognitive decline," AIP Publishing.
4. V. V. Giau, E. Bagyinszky, Y. S. Yang, et al., "Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing," Scientific Reports, 9(1), 8368 (2019).
5. C.-Q. Chu, L.-l. Yu, G.-y. Qi, et al., "Can dietary patterns prevent cognitive impairment and reduce Alzheimer's disease risk: Exploring the underlying mechanisms of effects," Neuroscience & Biobehavioral Reviews, 135, 104556 (2022).
6. G. A. Carlson,S. B. Prusiner, "How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer’s Disease and Other Neurodegenerative Disorders," International Journal of Molecular Sciences, 22(9), 4861 (2021).
7. F. Leng,P. Edison, "Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?," Nature Reviews Neurology, 17(3), 157-172 (2021).
8. T. Li, L. Lu, E. Pember, et al., "New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention," Cells, 11(12), 1925 (2022).
9. J. Rogers, S. Webster, L. F. Lue, et al., "Inflammation and Alzheimer's disease pathogenesis," Neurobiol Aging, 17(5), 681-6 (1996).
10. Y. Yao, C. Chinnici, H. Tang, et al., "Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis," J Neuroinflammation, 1(1), 21 (2004).
11. J. A. S. Gomes, J. F. Silva, A. P. Marcal, et al., "High-refined carbohydrate diet consumption induces neuroinflammation and anxiety-like behavior in mice," J Nutr Biochem, 77, 108317 (2020).
12. M. S. Wu, P. Johnston, W. H. Sheu, et al., "Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients," Diabetes Care, 13(1), 1-8 (1990).
13. M. J. Butler, N. P. Deems, S. Muscat, et al., "Dietary DHA prevents cognitive impairment and inflammatory gene expression in aged male rats fed a diet enriched with refined carbohydrates," Brain Behav Immun, 98, 198-209 (2021).
14. E. J. Yang, J. M. Kerver, Y. K. Park, et al., "Carbohydrate intake and biomarkers of glycemic control among US adults: the third National Health and Nutrition Examination Survey (NHANES III)," Am J Clin Nutr, 77(6), 1426-33 (2003).
15. K. B. M P Vitek, J M Glendening , E Stopa, H Vlassara, R Bucala, K Manogue and A Cerami, Advanced glycation end products contribute to amyloidosis in Alzheimer disease., PNAS, 1994).
16. S. P. Banik, M. Bhattacharyya, R. Ghosh, et al., "Chapter 11 - Glycation-induced protein aggregation and cellular toxicity: an insight into the disease realm of high dietary sugar intake," in: Dietary Sugar, Salt and Fat in Human Health,edited by Preuss Harry G., Bagchi Debasis(Academic Press, 2020), pp. 251-275.
17. N. Sasaki, R. Fukatsu, K. Tsuzuki, et al., "Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Diseases," The American Journal of Pathology, 153(4), 1149-1155 (1998).
18. N. Flores-Fuentes, C. Hernandez-Cruz, K. Bermeo, et al., "Motor learning impairment in rats under a high sucrose diet," Physiol Behav, 234, 113384 (2021).
19. J. E. Beilharz, J. Maniam,M. J. Morris, "Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional Interventions," Nutrients, 7(8), 6719-38 (2015).
20. M. A. W. Hawkins, N. G. Keirns,Z. Helms, "Carbohydrates and cognitive function," Curr Opin Clin Nutr Metab Care, 21(4), 302-307 (2018).
21. S. H. Yeh, F. S. Shie, H. K. Liu, et al., "A high-sucrose diet aggravates Alzheimer's disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice," Neurobiol Aging, 90, 60-74 (2020).
22. F. A. H. SARDÁ, E. B. GIUNTINI, J.-A. NAZARE, et al., "Effectiveness of carbohydrates as a functional ingredient in glycemic control," 38(4), 561-576 (2018).
23. G. Marwarha,O. Ghribi, "Leptin signaling and Alzheimer's disease," Am J Neurodegener Dis, 1(3), 245-65 (2012).
24. R. T. PM Insel, D Ross, Carbohydrates: Simple sugars and complex chains. Discovering Nutrition, 2006, pp. 103-133.
25. M. Lilamand, B. Porte, E. Cognat, et al., "Are ketogenic diets promising for Alzheimer’s disease? A translational review," Alzheimer's Research & Therapy, 12(1), 42 (2020).
26. M. Ota, J. Matsuo, I. Ishida, et al., "Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement," Psychopharmacology, 233(21), 3797-3802 (2016).
27. M. Ota, J. Matsuo, I. Ishida, et al., "Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease," Neuroscience Letters, 690, 232-236 (2019).
28. S. T. Henderson, "Ketone bodies as a therapeutic for Alzheimer’s disease," Neurotherapeutics, 5(3), 470-480 (2008).
29. I. Van Der Auwera, S. Wera, F. Van Leuven, et al., "A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease," Nutrition & Metabolism, 2(1), 28 (2005).
30. A. D. Mooradian, "The Merits and the Pitfalls of Low Carbohydrate Diet: A Concise Review," The journal of nutrition, health & aging, 24(7), 805-808 (2020).
31. P. Londzin, M. Zamora, B. Kąkol, et al., "Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies," Nutrients, 13(2), 537 (2021).
32. A. A. Gomaa, H. S. M. Farghaly, A. M. Ahmed, et al., "Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia," Eur J Pharmacol, 921, 174873 (2022).
33. J. K. Morris,J. M. Burns, "Insulin: an emerging treatment for Alzheimer's disease dementia?," Curr Neurol Neurosci Rep, 12(5), 520-7 (2012).
34. H. Akimoto, A. Negishi, S. Oshima, et al., "Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS," Am J Alzheimers Dis Other Demen, 35, 1533317519899546 (2020).
35. H. J. Lee, H. I. Seo, H. Y. Cha, et al., "Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects," Clin Nutr Res, 7(4), 229-240 (2018).
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Biological Engineering and Medical Science (ICBioMed 2022), Part II
- ISBN (Print)
- 978-1-915371-27-0
- ISBN (Online)
- 978-1-915371-28-7
- Published Date
- 28 April 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/4/20220510
- Copyright
- 28 April 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited